Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Lyubka Tancheva, Maria Cristina Petralia, Simona Miteva, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 852-852
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic
Karen B. Jacobson, Mallika Rao, Hector Bonilla, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 3, pp. e826-e829
Open Access | Times Cited: 167
A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
Glenn Jennings, Ann Monaghan, Xue Feng, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5913-5913
Open Access | Times Cited: 130
Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
Michał Chudzik, Mateusz Babicki, Joanna Kapusta, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1755-1755
Open Access | Times Cited: 49
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Maria Fernanda Pessano Fialho, Evelyne da Silva Brum, Sara Marchesan Oliveira
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 633-651
Open Access | Times Cited: 25
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients
Y. Lavi, Aristo Vojdani, Gilad Halpert, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 687-687
Open Access | Times Cited: 21
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.
Ralitza Alexova, Simona Alexandrova, Stela Dragomanova, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3772-3772
Open Access | Times Cited: 18
Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
Stela Dragomanova, Simona Miteva, Ferdinando Nicoletti, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1294-1294
Open Access | Times Cited: 32
Serum Brain-Derived Neurotrophic Factor (BDNF) in COVID-19 Patients and its Association with the COVID-19 Manifestations
Ali Asgarzadeh, Nasrin Fouladi, Vahid Asghariazar, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 9, pp. 1820-1830
Open Access | Times Cited: 24
Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19
Christos Tsagkaris, Muhammad Bilal, İrem Aktar, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 9, pp. 641-657
Closed Access | Times Cited: 22
A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: Ongoing symptomatic phase vs. post-COVID-19 syndrome
Glenn Jennings, Ann Monaghan, Xue Feng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 28
Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches
Aisha Sodagar, Rasab Javed, Hira Tahir, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 971-971
Open Access | Times Cited: 20
Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea
Hyun Kyung Kim, Yeo Jeong Cho, Seo‐Young Lee
Journal of Clinical Neurology (2021) Vol. 17, Iss. 3, pp. 435-435
Open Access | Times Cited: 18
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery
Yu Wu, Miora Rakotoarisoa, Borislav Angelov, et al.
Nanomaterials (2022) Vol. 12, Iss. 13, pp. 2267-2267
Open Access | Times Cited: 12
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics
К. Ray Chaudhuri, Katarina Rukavina, Victor McConvey, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 6, pp. 615-623
Open Access | Times Cited: 16
Prevalence and assessment of risk factors among Polish adults with post-COVID syndrome: 12-month follow-up study
Mateusz Babicki, Damian Kołat, Joanna Kapusta, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 6
Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences
Helia Jafari Khaljiri, Monire Jamalkhah, Ali Amini Harandi, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 5, pp. 1613-1629
Open Access | Times Cited: 14
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
Omid Mirmosayyeb, Elham Moases Ghaffary, Mohammad Sadegh Dehghan, et al.
Journal of Central Nervous System Disease (2023) Vol. 15, pp. 117957352311678-117957352311678
Open Access | Times Cited: 5
Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-term Symptoms of COVID-19 After Recovery: A Review
Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 852-868
Closed Access | Times Cited: 9
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
Jeremy M. Morowitz, Kaylyn Pogson, Daniel Roque, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 536-536
Open Access | Times Cited: 8
SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability
Tiziana Casoli
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3782-3782
Open Access | Times Cited: 7
Drug‐induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies
Mohammad Mehdi Ommati, Ali Mobasheri, Reza Heidari
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 7
Open Access | Times Cited: 9
Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019
Mehdi Shahbazi, Mohammad Jafari, Zahra Moulana, et al.
Apmis (2021) Vol. 129, Iss. 5, pp. 271-279
Open Access | Times Cited: 8
First-episode psychotic disorders in the wake of the COVID-19 pandemic: a descriptive review of casereports
Hans Rittmannsberger, Martin Barth, Peter Malík, et al.
Acta Neuropsychiatrica (2022) Vol. 34, Iss. 6, pp. 289-310
Open Access | Times Cited: 5
New-Onset Seizures in Patients With COVID-19: A Case Series From a Single Public Hospital in Korea
Yeo Jeong Cho, Hyun Kyung Kim
Journal of Korean Medical Science (2022) Vol. 37, Iss. 12
Open Access | Times Cited: 4
Perda de memória associada à infecção viral por SARS-CoV-2: Revisão de literatura
Ingrid Nascimento Lima, Caroline Yumi Yamamoto, Jennefer de Sousa Luz, et al.
Research Society and Development (2022) Vol. 11, Iss. 4, pp. e49011427609-e49011427609
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top